Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuftsin-THF-gamma 2 chimeric peptides: potential novel immunomodulators

R Granoth1, E Vadai, Y Burstein

  • 1Department of Organic Chemistry, Weizmann Institute of Science, Rehovot, Israel.

Immunopharmacology
|August 1, 1997
PubMed
Summary

Researchers synthesized novel immunomodulators by conjugating tuftsin and thymic humoral factor-gamma 2 (THF-gamma 2). The resulting chimeric peptides showed maintained IL-6 induction and enhanced antigen presentation, suggesting therapeutic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuftsin-phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model.

Clinical and experimental immunology·2018
Same author

Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis.

Clinical and experimental immunology·2015
Same author

From antioxidant chelators to site-activated multi-target chelators targeting hypoxia inducing factor, beta-amyloid, acetylcholinesterase and monoamine oxidase A/B.

Mini reviews in medicinal chemistry·2012
Same author

Long-term results of the Israeli National Studies in childhood acute lymphoblastic leukemia: INS 84, 89 and 98.

Leukemia·2009
Same author

Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditions.

Journal of controlled release : official journal of the Controlled Release Society·2009
Same author

A universal epitope-based influenza vaccine and its efficacy against H5N1.

Vaccine·2009

Area of Science:

  • Immunology
  • Peptide Chemistry
  • Drug Discovery

Background:

  • Tuftsin stimulates phagocytic cells and enhances IL-6 production in macrophages, particularly with antigen presence.
  • Thymic humoral factor-gamma 2 (THF-gamma 2) is a T cell stimulant with known benefits in myeloid colony formation.
  • Novel immunomodulators are sought for therapeutic applications.

Purpose of the Study:

  • To synthesize and evaluate chimeric peptides combining tuftsin and THF-gamma 2.
  • To assess the immunomodulatory activities of these novel conjugates.
  • To explore their potential as therapeutic agents.

Main Methods:

  • Synthesis of two chimeric peptides: H2N-tuftsin-THF-gamma 2-OH and H2N-THF-gamma 2-tuftsin-OH.
  • Evaluation of IL-6 induction in murine macrophages with and without antigen (KLH, lysozyme).

Related Experiment Videos

  • Assessment of myeloid colony formation in murine bone marrow.
  • Testing in a combined macrophages-T cells antigen presentation assay.

    • Main Results:

    • Tuftsin induced IL-6 in macrophages dose-dependently, requiring antigen.
    • Chimeric peptides maintained IL-6 induction but required higher concentrations than tuftsin.
    • Chimeric peptides were inactive in enhancing myeloid colony formation.
    • H2N-tuftsin-THF-gamma 2-OH demonstrated enhanced activity in antigen presentation compared to parent peptides.

    Conclusions:

    • Chimeric peptides retain some immunomodulatory functions of parent molecules.
    • H2N-tuftsin-THF-gamma 2-OH shows promise as a therapeutic agent due to enhanced antigen presentation.
    • Further research is warranted to explore the therapeutic potential of these novel immunomodulators.